TY - JOUR
T1 - New strategies in the management of valvular heart disease
T2 - A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease
AU - Lamm, Gudrun
N1 - Publisher Copyright:
© 2021, Springer-Verlag GmbH Austria, part of Springer Nature.
PY - 2021/8
Y1 - 2021/8
N2 - The advent of transcatheter procedures for treatment of valvular heart disease has accelerated the pace of research in the diagnosis and treatment of heart valve disease. Rapid accumulation of novel knowledge in the field necessitates timely revisions of clinical guidelines. This paper comments on some important and novel issues addressed in the recently published American College of Cardiology/American Heart Association (ACC/AHA) guidelines.
AB - The advent of transcatheter procedures for treatment of valvular heart disease has accelerated the pace of research in the diagnosis and treatment of heart valve disease. Rapid accumulation of novel knowledge in the field necessitates timely revisions of clinical guidelines. This paper comments on some important and novel issues addressed in the recently published American College of Cardiology/American Heart Association (ACC/AHA) guidelines.
KW - American Heart Association
KW - Cardiology
KW - Heart Valve Diseases/surgery
KW - Humans
KW - Transcatheter Aortic Valve Replacement
KW - United States
UR - http://www.scopus.com/inward/record.url?scp=85103261106&partnerID=8YFLogxK
U2 - 10.1007/s00508-021-01879-y
DO - 10.1007/s00508-021-01879-y
M3 - Review article
C2 - 34057577
SN - 0043-5325
VL - 133
SP - 786
EP - 789
JO - Wiener Klinische Wochenschrift
JF - Wiener Klinische Wochenschrift
IS - 15-16
ER -